Researchers have identified cuproptosis as a potential target for breast cancer therapy, which may make cancer cells vulnerable to immune destruction. The process of cuproptosis is being explored for its therapeutic opportunities, including the use of targeted nanoparticles and copper-based nanoplatforms to destroy tumor cells. Studies on cuproptosis are also being conducted in the context of other types of cancer, such as gastric cancer, to further understand its role and potential applications.